Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity.
|
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
nUQ6bwpsd7fNuWkG